Jinhe Biotechnology Co., Ltd. (002688)

Overview

Jinhe Biotechnology CO., LTD., established in 1990, is a prominent player in the Chinese veterinary medicine market, specializing in the production and sales of various veterinary drugs. With its headquarters located in Dalian, China, Jinhe Biotechnology has carved out a significant presence both domestically and internationally. The company is recognized for its dedication to developing and providing antimicrobial drugs to address a wide spectrum of diseases affecting poultry and livestock. Besides its strong market presence in China, Jinhe Biotechnology has successfully expanded its reach to various global markets, including the United States, South-east Asia, Latin America, and Europe, reflecting its commitment to fulfilling the veterinary medicine needs on a global scale.

Products and Services

• Chlortetracycline Feed Grade

  This product is an antimicrobial drug utilized primarily in the feed of poultry and livestock. It serves the crucial function of inhibiting and treating bacterial infections such as white dysentery, enteritis, pneumonia, typhoid, paratyphoid, and cholera among animals. Its widespread use underscores the reliability and efficacy of this product in preventing and combatting infectious diseases in farm animals.

• Chlortetracycline Hydrochloride

  A derivative of chlortetracycline, this compound is specifically formulated for the inhibition and treatment of various bacterial diseases in poultry and livestock, including pullorum disease, typhoid, swine enteritis, paratyphoid, and cholera. Chlortetracycline hydrochloride represents Jinhe Biotechnology’s dedication to broadening its product range to meet the diverse needs of the veterinary sector.